PHK
PASG icon

Point72 Hong Kong’s Passage Bio PASG Stock Holding History

Point72 Hong Kong’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-170
Closed -$4K – 1238
2022
Q3 		$4K Buy
+170
New +$6.7K ﹤0.01% 1812
2022
Q2 		– Sell
-98
Closed -$6K – 2297
2022
Q1 		$6K Buy
98
+64
+188% +$5.28K ﹤0.01% 1661
2021
Q4 		$4K Sell
34
-87
-72% -$14.2K ﹤0.01% 1745
2021
Q3 		$24K Sell
121
-61
-34% -$14.5K ﹤0.01% 1664
2021
Q2 		$48K Buy
+182
New +$56.3K ﹤0.01% 1479

Other funds holding PASG

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Point72 Hong Kong's PASG Position: Q4 2022 in Review

Point72 Hong Kong sold out of Passage Bio (PASG) in Q4 2022, closing a stake of 170 shares — an estimated $4K sold.

Point72 Hong Kong first reported a position in PASG in Q2 2021 and held it in 5 quarters. The position peaked at $48K in Q2 2021. 67 funds tracked by Wall St. Rank hold PASG as of Q4 2022.

  • Point72 Hong Kong reported no remaining Passage Bio position as of Q4 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 170 Passage Bio shares in Q4 2022, an estimated $4K.
  • Point72 Hong Kong first reported a position in Passage Bio in Q2 2021 and held it in 5 quarters.
  • Point72 Hong Kong's Passage Bio position peaked at $48K in Q2 2021.
  • 67 funds tracked by Wall St. Rank held Passage Bio as of Q4 2022.

Based on Point72 Hong Kong's 13F filing for Q4 2022, filed 14 Feb 2023.